n the third episode of this series on MHT, We discuss the critical topic of the history of women and people with uteruses and ovaries in clinical research. The episode dives into how these groups were only regularly included in clinical studies from the 1990s and discusses the consequences of this. Bree Luck unpacks the effects of this shift on menopausal hormone therapy, its efficacy, risks involved, and also the terms often involved in understanding related studies.